These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34970764)

  • 1. Letter: evaluation and proposed reclassification of HCC prediction model of Tahata et al. in chronic hepatitis C genotype 4 patient. Authors' reply.
    Tahata Y; Sakamori R; Yamada R; Kodama T; Hikita H; Hagiwara H; Imai Y; Hiramatsu N; Tamura S; Yamamoto K; Oshita M; Ohkawa K; Hijioka T; Fukui H; Ito T; Doi Y; Yamada Y; Yakushijin T; Yoshida Y; Tatsumi T; Takehara T;
    Aliment Pharmacol Ther; 2022 Jan; 55(2):258-259. PubMed ID: 34970764
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: evaluation and proposed re-classification of HCC prediction model in patients with chronic hepatitis C genotype 4.
    Shiha G; Mikhail NNH; Soliman R
    Aliment Pharmacol Ther; 2022 Jan; 55(2):255-257. PubMed ID: 34970766
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients.
    Arafa M; Besheer T; El-Eraky AM; Abo El-Khair SM; Elsamanoudy AZ
    Br J Biomed Sci; 2019 Apr; 76(2):64-69. PubMed ID: 31025604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
    Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
    Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lnc-HOTAIR predicts hepatocellular carcinoma in chronic hepatitis C genotype 4 following direct-acting antivirals therapy.
    El-Khazragy N; Elshimy AA; Hassan SS; Shaaban MH; Bayoumi AH; El Magdoub HM; Ghozy S; Gaballah A; Aboelhussein MM; Abou Gabal HH; Bannunah AM; Mansy AE
    Mol Carcinog; 2020 Dec; 59(12):1382-1391. PubMed ID: 33074585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
    Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
    Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines and liver injury in chronic HCV genotype 4 infection.
    Zekry A
    J Gastroenterol Hepatol; 2009 Mar; 24(3):332-5. PubMed ID: 19335783
    [No Abstract]   [Full Text] [Related]  

  • 8. Two sides of a coin: GG genotype of C7 provides protection against fibrosis severity while showing a higher risk for hepatocellular carcinoma in patients with hepatitis C.
    de Lima RE; de Holanda Martins CM; do Carmo RF; Aroucha DCBL; Pereira LMMB; Vasconcelos LRS; Moura P
    Hum Immunol; 2018 Sep; 79(9):702-707. PubMed ID: 29966690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications.
    Lee CM; Lu SN; Hung CH; Tung WC; Wang JH; Tung HD; Chen CH; Hu TH; Changchien CS; Chen WJ
    Trans R Soc Trop Med Hyg; 2006 Aug; 100(8):767-74. PubMed ID: 16443243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation degree of metalloproteinase inhibitor RECK gene: Links to RECK protein level and hepatocellular carcinoma in chronic HCV infection patients.
    Abo El-Khair SM; Elalfy H; Diasty M; Ebrahim EE; Elsamanoudy AZ
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22886. PubMed ID: 34392581
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Badawy AA; Othman G; Elabbasy LM; Abd Elsalam M; Shrief R; Fahmy EM; Kamel NM; Osman A; Zaki ME
    Br J Biomed Sci; 2019 Oct; 76(4):201-204. PubMed ID: 31314698
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of 32-bp deletion polymorphism and promoter methylation of
    Badawy AA; El-Rabat A; Elshazly TA; Ali SA; Alruwaili AM; Gad DF; Dawoud MG; Elmasry EE; Zaki ME
    Br J Biomed Sci; 2019 Oct; 76(4):195-197. PubMed ID: 31109254
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon-γ and Interleukin-10 Gene Polymorphisms are not Predictors of Chronic Hepatitis C (Genotype-4) Disease Progression.
    Bahgat NA; Kamal MM; Abdelaziz AO; Mohye MA; Shousha HI; ahmed MM; Elbaz TM; Nabil MM
    Asian Pac J Cancer Prev; 2015; 16(12):5025-30. PubMed ID: 26163635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
    Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
    Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
    Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of quasispecies diversity of HCV between chronic hepatitis c and hepatocellular carcinoma by Ultradeep pyrosequencing.
    Park CW; Cho MC; Hwang K; Ko SY; Oh HB; Lee HC
    Biomed Res Int; 2014; 2014():853076. PubMed ID: 24999482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HCV-related hepatocellular carcinoma].
    Otsuka M; Kato N; Yoshida H; Yoshida H; Shiratori Y; Omata M
    Uirusu; 2002 Dec; 52(2):295-300. PubMed ID: 12685322
    [No Abstract]   [Full Text] [Related]  

  • 19. IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients.
    Elsayed HM; Nabiel Y; Sheta T
    Immunol Invest; 2017 Feb; 46(2):123-133. PubMed ID: 27819525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants in IL-6 and IL-10 genes and susceptibility to hepatocellular carcinoma in HCV infected patients.
    Sghaier I; Mouelhi L; Rabia NA; Alsaleh BR; Ghazoueni E; Almawi WY; Loueslati BY
    Cytokine; 2017 Jan; 89():62-67. PubMed ID: 28340949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.